PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES

PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES

The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WOOSTER RICHARD FRANCIS, VALLANCE PATRICK JOHN THOMPSON, LUKEY PAULINE TERESA
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WOOSTER RICHARD FRANCIS
VALLANCE PATRICK JOHN THOMPSON
LUKEY PAULINE TERESA
description The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2015051215A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2015051215A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2015051215A13</originalsourceid><addsrcrecordid>eNrjZNAL8DT2VvD08_B08gzxDwpWcPMPUggJcnUM8fRzV3DzdAryD_F0VnDxDHZ1DHYN5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGpgamhkaGpo6GxsSpAgByASaP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES</title><source>esp@cenet</source><creator>WOOSTER RICHARD FRANCIS ; VALLANCE PATRICK JOHN THOMPSON ; LUKEY PAULINE TERESA</creator><creatorcontrib>WOOSTER RICHARD FRANCIS ; VALLANCE PATRICK JOHN THOMPSON ; LUKEY PAULINE TERESA</creatorcontrib><description>The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150219&amp;DB=EPODOC&amp;CC=US&amp;NR=2015051215A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150219&amp;DB=EPODOC&amp;CC=US&amp;NR=2015051215A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WOOSTER RICHARD FRANCIS</creatorcontrib><creatorcontrib>VALLANCE PATRICK JOHN THOMPSON</creatorcontrib><creatorcontrib>LUKEY PAULINE TERESA</creatorcontrib><title>PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES</title><description>The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAL8DT2VvD08_B08gzxDwpWcPMPUggJcnUM8fRzV3DzdAryD_F0VnDxDHZ1DHYN5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGpgamhkaGpo6GxsSpAgByASaP</recordid><startdate>20150219</startdate><enddate>20150219</enddate><creator>WOOSTER RICHARD FRANCIS</creator><creator>VALLANCE PATRICK JOHN THOMPSON</creator><creator>LUKEY PAULINE TERESA</creator><scope>EVB</scope></search><sort><creationdate>20150219</creationdate><title>PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES</title><author>WOOSTER RICHARD FRANCIS ; VALLANCE PATRICK JOHN THOMPSON ; LUKEY PAULINE TERESA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2015051215A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>WOOSTER RICHARD FRANCIS</creatorcontrib><creatorcontrib>VALLANCE PATRICK JOHN THOMPSON</creatorcontrib><creatorcontrib>LUKEY PAULINE TERESA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WOOSTER RICHARD FRANCIS</au><au>VALLANCE PATRICK JOHN THOMPSON</au><au>LUKEY PAULINE TERESA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES</title><date>2015-02-19</date><risdate>2015</risdate><abstract>The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2015051215A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T16%3A15%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WOOSTER%20RICHARD%20FRANCIS&rft.date=2015-02-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2015051215A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true